Michael L. C. Beagan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael L. C. Beagan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Emil Andersen
Department of Clinical Microbiology, Odense University Hospital and Research Unit of Clinical Microbiology, University of Southern Denmark, 5000 Odense, Denmark
2 shared publications - Chris Halling Dreyer
Department of Orthopedic Surgery and Traumatology, Odense University Hospital, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Orthopaedic Surgery and Traumatology, CORI - Centre for Orthopaedic Research and Innovation, Naestved-Slagelse-Ringsted Hospital, Denmark
1 shared publication Henrik E. Jensen
University of Copenhagen, Copenhagen, Denmark
1 shared publication- Jens Sivkær Pettersen
Department of Biochemistry and Molecular Biology, University of Southern Denmark
1 shared publication - Line Lundegaard Bang
Odense Univ Hosp, Dept Clin Microbiol, Odense, Denmark
1 shared publication Louise K. Jensen
University of Copenhagen, Copenhagen, Denmark
1 shared publication
Latest Publications
- Open Access
- 9 May 2024
- Published by Springer Nature in Journal of Applied Phycology
- Vol. 36 (4) , 2199-2208
Fucoidans from Laminaria hyperborea demonstrate bactericidal activity against diverse bacteria
Fucoidans are a heterogenous class of fucose-rich sulfated carbohydrates which have attracted increasing attention in cancer and inflammation research due to their bioactive properties. There are reports that fucoidans may have direct antibacterial effects and synergy with antibiotics. However, the literature is conflicting, potentially due to the limited reporting of origin, characteristics, and extraction methods of the fucoidans tested. Here we report the results of 18 defined fucoidans screened for direct, indirect, and synergistic antibacterial effects. 15 distinct fucoidan fractions, isolated from Laminaria hyperborea using a solvent-free extraction process, were characterised for molecular weight, pH, viscosity, and sulfur content. These, together with three commercially available crude fractions, were assessed at concentrations from 0.03125-24 mg mL-1 for minimum inhibitory concentration against Staphylococcus aureus, Streptococcus mutans and Streptococcus sanguinis. Furthermore, we tested a selection of fucoidans for antibacterial synergy with vancomycin and indirect antibacterial effects in whole blood survival assays. Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) was performed to assess the stress response in fucoidan-treated S. aureus cultures. We have identified one fucoidan fraction with bactericidal activity against diverse bacteria. This effect is dose-, fucoidan fraction- and bacteria-specific, and furthermore, not related to osmotic stress. No synergistic effects were observed with fucoidan in combination vancomycin. Fucoidans have exciting potential as antimicrobial agents. Further analysis is required to establish the precise molecular characteristics responsible for their potent bactericidal activity.
- 9 May 2024
- Published by Springer Nature in Journal of Applied Phycology
- Vol. 36 (4) , 2199-2208
Open AccessFucoidans from Laminaria hyperborea demonstrate bactericidal activity against diverse bacteria
Fucoidans are a heterogenous class of fucose-rich sulfated carbohydrates which have attracted increasing attention in cancer and inflammation research due to their bioactive properties. There are reports that fucoidans may have direct antibacterial effects and synergy with antibiotics. However, the literature is conflicting, potentially due to the limited reporting of origin, characteristics, and extraction methods of the fucoidans tested. Here we report the results of 18 defined fucoidans screened for direct, indirect, and synergistic antibacterial effects. 15 distinct fucoidan fractions, isolated from Laminaria hyperborea using a solvent-free extraction process, were characterised for molecular weight, pH, viscosity, and sulfur content. These, together with three commercially available crude fractions, were assessed at concentrations from 0.03125-24 mg mL-1 for minimum inhibitory concentration against Staphylococcus aureus, Streptococcus mutans and Streptococcus sanguinis. Furthermore, we tested a selection of fucoidans for antibacterial synergy with vancomycin and indirect antibacterial effects in whole blood survival assays. Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) was performed to assess the stress response in fucoidan-treated S. aureus cultures. We have identified one fucoidan fraction with bactericidal activity against diverse bacteria. This effect is dose-, fucoidan fraction- and bacteria-specific, and furthermore, not related to osmotic stress. No synergistic effects were observed with fucoidan in combination vancomycin. Fucoidans have exciting potential as antimicrobial agents. Further analysis is required to establish the precise molecular characteristics responsible for their potent bactericidal activity.
- Open Access
- 19 March 2024
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 45, 120-131
The potential of sheep in preclinical models for bone infection research – A systematic review
- 19 March 2024
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 45, 120-131
Open AccessThe potential of sheep in preclinical models for bone infection research – A systematic review